Egalet Corporation has announced that the FDA has approved Arymo ER (morphine sulfate) extended-release (ER) tablets C-II for the management...
The FDA has approved MorphaBond (morphine sulfate extended-release) tablets, for oral use, from Inspirion Delivery Technologies. MorphaBond is an abuse-deterrent...
Egalet Corporation announced that the FDA has accepted the new drug application (NDA) for Arymo ER (morphine sulfate) extended-release tablets....
Egalet Corporation has announced the company has submitted a new drug application (NDA) for Arymo ER (morphine sulfate) extended-release tablets...